CD36 Gene Platelet glycoprotein IV deficiency Genetic Test
Test Name: CD36 Gene Platelet glycoprotein IV deficiency Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hematology
Doctor: Hematologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic DNA Test gene CD36
Test Details
The CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic Test is a genetic test that analyzes the CD36 gene for any mutations or variations that may be associated with Platelet glycoprotein IV deficiency. This test uses Next-Generation Sequencing (NGS) technology to sequence the entire CD36 gene and identify any changes in the DNA sequence that may be linked to the disorder.
Platelet glycoprotein IV deficiency is a rare genetic disorder characterized by a deficiency or dysfunction of the CD36 protein on the surface of platelets. This can lead to an increased risk of bleeding and other complications. The CD36 gene provides instructions for making the CD36 protein, and mutations in this gene can disrupt the normal function of the protein.
The NGS Genetic Test for CD36 Gene Platelet glycoprotein IV deficiency aims to identify any mutations or variations in the CD36 gene that may be contributing to the disorder. This information can help in diagnosing the condition, assessing the risk of complications, and guiding treatment decisions.
The test involves collecting a sample of DNA, usually through a blood or saliva sample, and then sequencing the CD36 gene using NGS technology. The DNA sequence is compared to a reference sequence to identify any differences or variations. These variations are then analyzed to determine if they are likely to cause Platelet glycoprotein IV deficiency.
Overall, the CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic Test is a valuable tool for diagnosing and managing this rare genetic disorder. It can provide important information about the genetic cause of the condition, which can help guide treatment decisions and provide information for family planning.
| Test Name | CD36 Gene Platelet glycoprotein IV deficiency Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hematology |
| Doctor | Hematologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic DNA Test gene CD36 |
| Test Details |
CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic Test is a genetic test that analyzes the CD36 gene for any mutations or variations that may be associated with Platelet glycoprotein IV deficiency. This test uses Next-Generation Sequencing (NGS) technology to sequence the entire CD36 gene and identify any changes in the DNA sequence that may be linked to the disorder. Platelet glycoprotein IV deficiency is a rare genetic disorder characterized by a deficiency or dysfunction of the CD36 protein on the surface of platelets. This can lead to an increased risk of bleeding and other complications. The CD36 gene provides instructions for making the CD36 protein, and mutations in this gene can disrupt the normal function of the protein. The NGS Genetic Test for CD36 Gene Platelet glycoprotein IV deficiency aims to identify any mutations or variations in the CD36 gene that may be contributing to the disorder. This information can help in diagnosing the condition, assessing the risk of complications, and guiding treatment decisions. The test involves collecting a sample of DNA, usually through a blood or saliva sample, and then sequencing the CD36 gene using NGS technology. The DNA sequence is compared to a reference sequence to identify any differences or variations. These variations are then analyzed to determine if they are likely to cause Platelet glycoprotein IV deficiency. Overall, the CD36 Gene Platelet glycoprotein IV deficiency NGS Genetic Test is a valuable tool for diagnosing and managing this rare genetic disorder. It can provide important information about the genetic cause of the condition, which can help guide treatment decisions and provide information for family planning. |
